Letters by company

Aroa Biosurgery Ltd

1 letter discussing ARX. Everything written about it on this site is on its ticker page.

Forager Funds Management Monthly Report April 2026 Forager Australian Shares Fund deployed cash amid volatility, reducing its cash position as smaller industrials lagged while resources and technology rallied. Cuscal’s Paymark acquisition was viewed as a logical, accretive use of capital, while EML Payments cut expectations and Hipages and Aroa reported favourable operating updates. April 2026 CCL $849M